Home Contact Sitemap

eRAM

encyclopedia of Rare Disease Annotation for Precision Medicine




Disease open-angle glaucoma
Symptom C0021888|intraocular pressure
Sentences 65
PubMedID- 23269858 Background: this study was designed to evaluate the occurrence and severity of ocular hyperemia in subjects with elevated intraocular pressure (iop) due to primary open angle glaucoma (poag) or ocular hypertension (oht) following treatment with bimatoprost 0.01% in a real-world clinical setting.
PubMedID- 23009074 Goldmann applanation tonometry compared with corneal-compensated intraocular pressure in the evaluation of primary open-angle glaucoma.
PubMedID- 21849211 Among the remaining studies, level ii evidence supports the efficacy of selective laser trabeculoplasty for lowering intraocular pressure for patients with open-angle glaucoma.
PubMedID- 24771165 Results: two patients with primary open-angle glaucoma underwent canaloplasty because of medically uncontrolled intraocular pressure (iop).
PubMedID- 23111175 Purpose: to investigate the effect of change of body posture from the supine to the lateral decubitus position on intraocular pressure (iop) in patients with open-angle glaucoma.
PubMedID- 25016793 Transient increase of intraocular pressure with primary open angle glaucoma patients associated with warm and cold seasons after long waiting time in an ophthalmology clinic.
PubMedID- 26155078 Methods: ninety adult male/female patients of 18-60 years of age, of either sex, suffering from open angle glaucoma with an intraocular pressure (iop) of more than 24 mm hg were enrolled in the study.
PubMedID- 23218823 Purpose: to compare the change in lamina cribrosa (lc) displacement in response to intraocular pressure (iop) lowering in patients with open-angle glaucoma (oag) using spectral-domain optical coherence tomography (sd-oct).
PubMedID- 24735011 Results: eighty open-angle glaucoma with normal baseline intraocular pressure patients and 4015 controls were included.
PubMedID- 20390038 Clinical studies have demonstrated its efficacy at decreasing intraocular pressure in patients with open-angle glaucoma or ocular hypertension.
PubMedID- 24204049 Changes in the lamina and prelamina after intraocular pressure reduction in patients with primary open-angle glaucoma and acute primary angle-closure.
PubMedID- 20225997 Primary open angle glaucoma without satisfying intraocular pressure (iop) control (> or =21 mmhg) despite maximally tolerated medication or with progression of the visual field and cataract was the indication for surgery.
PubMedID- 21543995 Purpose: to compare the longitudinal change of frequency doubling technology (fdt) perimetry and standard automated perimetry (sap) results in sap-normal hemifield in open-angle glaucoma (oag) eyes with low-to-normal intraocular pressure (iop).
PubMedID- 21873661 A population-based assessment of 24-hour intraocular pressure among subjects with primary open-angle glaucoma: the handan eye study.
PubMedID- 21216796 The authors report their initial clinical results with a novel wireless ocular telemetry sensor (ots) (sensimed ag, switzerland) for continuous intraocular pressure (iop) monitoring in patients with open angle glaucoma.
PubMedID- 22553666 Head trauma can cause transient elevation of intraocular pressure in patients with open angle glaucoma.
PubMedID- 21479271 One of the most common forms of glaucoma, primary open angle glaucoma, is associated with increased intraocular pressure.
PubMedID- 24286181 Purpose: the purpose of the present study was to elucidate the effects of several anti-glaucoma medications on the circadian intraocular pressure (iop) fluctuations in patients with primary open-angle glaucoma (poag).
PubMedID- 24689838 Conclusions: uc(3) procedure seems to be an effective and well tolerated method to reduce intraocular pressure in patients with primary open-angle glaucoma.
PubMedID- 25639001 Methods: a total of 52 eyes from 52 open-angle glaucoma (oag) patients, with elevated intraocular pressure (lop), were included in this cross-sectional study.
PubMedID- 26286384 Conclusions: both slt and topical medication demonstrate similar success rates and effectiveness in lowering intraocular pressure in patients with open-angle glaucoma.
PubMedID- 25719238 Purpose:: to describe a new association between nonsenile nuclear cataracts and pigmentary glaucoma in patients with controlled intraocular pressure (iop).
PubMedID- 24882991 Latanoprost 0.005% has received the european and the us approval as the first-line drug reducing the intraocular pressure in patients with open angle glaucoma or ocular hypertension.
PubMedID- 25897195 It is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension who are insufficiently responsive to beta-blockers.1 the side effects of topical dorzolamide hydrochloride, such as conjunctivitis, eyelid edema, and eye lid irritation, are well known.2 however, allergic contact dermatitis due to dorzolamide is rare, although it has been commonly used worldwide in patients with glaucoma.
PubMedID- 24822212 Background: to investigate the efficacy of selective laser trabeculoplasty (slt) for lowering intraocular pressure (iop) in patients with open angle glaucoma (oag) secondary to emulsified silicone oil (so).
PubMedID- 22320418 Purpose: to compare the efficacy and safety of dorzolamide hydrochloride 2%/timolol maleate 0.5% fixed combination (dtfc) with latanoprost 0.005%/timolol maleate 0.5% fixed combination (ltfc) on diurnal intraocular pressure (iop) in patients with primary open-angle glaucoma.
PubMedID- 22167545 Purpose: to assess the retrobulbar hemodynamic parameters in the ophthalmic artery (oa), central retinal artery (cra), and short posterior ciliary arteries (pca) after decreasing elevated intraocular pressure (iop) in patients with open-angle glaucoma (oag) by using color doppler imaging.
PubMedID- 23835670 Purpose: to evaluate the efficacy of selective laser trabeculoplasty (slt) versus argon laser trabeculoplasty (alt) in lowering the intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension secondary to pseudoexfoliation.
PubMedID- 22140308 However, their intake, particularly that of coffee, has been suggested to increase intraocular pressure (iop) in patients with open angle glaucoma/ocular hypertension.
PubMedID- 21127505 Purpose: to investigate factors associated with changes in optic nerve head (onh) topography after acute intraocular pressure (iop) reduction in patients with primary open-angle glaucoma (poag).
PubMedID- 24059679 Of 1,589 eligible people, we detected 284 (17.9%) cases of glaucoma overall, including 36 (2.3%) cases of primary open-angle glaucoma with intraocular pressure levels greater than 21 mmhg, 226 (14.2%) cases of normal-tension glaucoma and 25 (1.6%) cases of primary angle-closure glaucoma.
PubMedID- 21468336 Several different classes of drugs are available for the reduction of elevated intraocular pressure (iop) associated with open-angle glaucoma or ocular hypertension, including β-blockers, carbonic anhydrase inhibitors (cais), prostaglandin analogs (pgas), and α-2 agonists.
PubMedID- 21437058 Bimatoprost ophthalmic solution 0.03% (lumigan®; allergan, inc.) was initially developed as an ocular antihypertensive and, in 2001, was approved for the reduction of elevated intraocular pressure (iop) in patients with open-angle glaucoma or ocular hypertension.19 as a glaucoma treatment, bimatoprost ophthalmic solution 0.03% is administered as a drop into the affected eye once daily.
PubMedID- 22613602 Effect of high myopia on 24-hour intraocular pressure in patients with primary open-angle glaucoma.
PubMedID- 20590394 Primary open-angle glaucoma without satisfying intraocular pressure (iop) control (>or=21 mmhg) despite maximally tolerated medications or with progression of visual field and cataract was the indication for surgery.
PubMedID- 25213118 The intraocular pressure (iop) reduction with taf/tim in open-angle glaucoma and ocular hypertension is similar to that of other prostaglandin-timolol fixed-combination products.
PubMedID- 24232829 Design, setting, and participants: prospective clinical cohort study at kumamoto university hospital, kumamoto, japan, among patients 55 years or older having open-angle glaucoma with intraocular pressure (iop) of 22 mm hg or higher, including 39 phakic eyes (phakic group) and 25 pseudophakic eyes after phacoemulsification (pseudophakic group).
PubMedID- 23293509 Among these drugs, prostaglandin f2α (pgf2α) analogs have become the first-line agents in treating open angle glaucoma because of their reliable intraocular pressure-lowering effect, good compliance (once daily application), and fewer side effects.
PubMedID- 24481483 Objective to assess the effectiveness of intraocular pressure (iop)-lowering medications in patients with open-angle glaucoma.
PubMedID- 26107474 The effects of fixed combination of bimatoprost-timolol and travoprost-timolol on intraocular pressure in patients with primary open-angle glaucoma or ocular hypertension, previously on nonfixed combination of latanoprost and timolol.
PubMedID- 24027965 The effect of crystalline lens extraction on intraocular pressure in patients with primary open-angle glaucoma.
PubMedID- 21048514 Aim: to evaluate the efficacy and tolerability of flunarizine, a nonselective calcium channel blocker, on intraocular pressure (iop) in patients with open-angle glaucoma (oag) or ocular hypertension (oh).
PubMedID- 23111749 Background: we evaluated the relation of systemic blood pressure with intraday variations in ocular perfusion pressure and intraocular pressure in patients with primary open-angle glaucoma in a telemedical home monitoring scenario.
PubMedID- 24653751 intraocular pressure after phacoemulsification in patients with uncontrolled primary open angle glaucoma.
PubMedID- 24558609 To evaluate the short-term effect of standard automated perimetry (sap) testing on intraocular pressure (iop) in patients with open-angle glaucoma (oag).
PubMedID- 22171066 Primary open-angle glaucoma is associated with elevated intraocular pressure, which in turn is believed to result from impaired outflow of aqueous humour.
PubMedID- 21104187 Background: to determine if asymmetrical postural change-induced elevations in intraocular pressure (iop) in eyes of patients with primary open-angle glaucoma (poag) were associated with asymmetries in functional and structural damage.
PubMedID- 25088623 The elevated intraocular pressure (iop) of primary open-angle glaucoma is caused by impaired outflow of aqueous humor through the trabecular meshwork.
PubMedID- 25276082 Purpose: to compare the efficacy and safety of latanoprost, bimatoprost, travoprost and timolol in reducing intraocular pressure (iop) in patients with primary open angle glaucoma.
PubMedID- 21995983 Objective: selective laser trabeculoplasty (slt) and argon laser trabeculoplasty (alt) are used to lower intraocular pressure (iop) in patients with open-angle glaucoma (oag).

Page: 1 2